Skip to content
Translational Neuropharmacology Lab (Zanos Lab)

Translational Neuropharmacology Lab (Zanos Lab)

Our laboratory, based in Cyprus, employs molecular and systems neuroscience, behavioral pharmacology, as well as advanced computational methods to unravel the mysteries of brain diseases and identify targets for the development of novel and effective pharmacotherapies.

Menu
  • Home
  • News
  • Team Members
    • Lab Director
    • Current Team Members
    • Alumni
  • Research
  • Research Units
    • Translational Neuropharmacology Unit
    • Clinical Neuropsychopharmacology Unit
    • AI & Systems Bioinformatics Unit Cyprus
    • Genetic Epidemiology Unit
  • Facilities
  • Publications
  • Media
  • Join Us
  • Contact
  • More

Category: News

News

Zanos lab publishes a short review article on Major Depressive Disorder in Trends in Molecular Medicine

No Comments
| News

The Zanos Lab is pleased to announce the publication of a short review article in the Disease of the Month series of Trends in Molecular Medicine. The article, titled “Major depressive disorder: susceptibility, underlying mechanisms, and emerging therapies,” is authored by Dr. Anna Onisiforou, Mr. Morfeas Koumas, and the lab director, Dr. Panos Zanos. This […]

Read More »

Dr. Zanos appointed as science communication coordinator for European psychedelics research network

No Comments
| News

We are pleased to announce that Dr. Zanos has been appointed as Science Communication Coordinator for COST Action CA24130, titled “Psychedelic renaissance: turn on, tune in and drop in” (PSY-NET). This European research network brings together scientists, clinicians, industry partners, and regulatory bodies to advance research on psychedelics for therapeutic applications. Dr. Zanos’ appointment to […]

Read More »

Dr. Anna Onisiforou secures €100,000 ERC Vision funding for Multiple Sclerosis research

No Comments
| News

We are pleased to announce that Dr. Anna Onisiforou, Senior Scientist and Head of the AI & Systems Bioinformatics Unit of our lab, has secured €100,000 in funding through the ERC Vision program of the Research and Innovation Foundation of Cyprus. This outstanding achievement recognizes Dr. Onisiforou’s innovative research and her leadership in developing computational […]

Read More »

Zanos Lab research on ketamine’s therapeutic mechanisms in depression and Opioid Use Disorder was presented in a seminar at the University of Haifa

No Comments
| News

The Zanos Lab presented research on the neurobiological mechanisms underlying ketamine’s efficacy in treating both depression and substance use disorders. Dr. Zanos, Director of the Translational Neuropharmacology Lab, delivered a talk detailing the lab’s multifaceted approach to understanding how ketamine and its metabolites can address two of the most pressing public health challenges of our […]

Read More »

Our Ph.D. student, Despina Melanthiou, featured in national newspaper article on Misophonia research

No Comments
| News

We are pleased to announce that Despina Melanthiou, a PhD student in the Zanos Lab, was featured in an article published in Politis newspaper on December 14, 2025, discussing her research on misophonia and its neurological underpinnings. The article, titled “When Everyday Sounds Become Pathologically Unbearable,” explores misophonia as a neurological condition that affects approximately […]

Read More »

Our Ph.D. student Morfeas Koumas authors public article on Opioid Use Disorder

No Comments
| News

We’re pleased to share that Morfeas Koumas, PhD student in the Zanos Lab, has published an article in Neolaia (Youth), a Cyprus-based journal, as part of the dissemination efforts for our PROUD study. The article, titled “Opioid Use Disorder: A Growing Public Health Challenge,” provides an accessible overview of opioid use disorder and discusses emerging therapeutic approaches, […]

Read More »

Scientific symposium: Addressing opioid addiction through interdisciplinary approaches

No Comments
| News

The Zanos Lab and the PROUD project team successfully hosted a scientific symposium titled “Addressing Opioid Addiction: Interdisciplinary Approaches” on December 5 at the University of Cyprus Library Amphitheater LRC012. This symposium brought together leading experts from psychiatry, clinical psychology, neuropharmacology, and community advocacy to discuss comprehensive approaches to understanding and treating opioid use disorder, […]

Read More »

Translational Neuropharmacology Lab awarded €535,000.00 Horizon Europe funding

No Comments
| News

The Translational Neuropharmacology Lab at the University of Cyprus has been awarded funding for the EXPOSIGNALZ HOP-ON project under the Horizon Europe HORIZON-WIDERA-2025-03 call. The proposal received the maximum evaluation score of 15.00/15.00, with perfect scores across all three assessment criteria: Excellence, Impact, and Quality and Efficiency of Implementation. This 48-month research initiative, conducted in […]

Read More »

Zanos lab presents PROUD study findings at NeuroGeorgia 2025 international neuroscience conference

No Comments
| News

The Zanos Lab recently presented groundbreaking findings from the PROUD clinical trial at the NeuroGeorgia 2025 International Neuroscience Conference. The presentation, delivered by the PROUD research team, showcased the first randomized controlled trial results examining ketamine’s antidepressant efficacy and underlying neurobiological mechanisms in individuals with opioid use disorder during abstinence maintenance. This pioneering work addresses […]

Read More »

Misophonia Research Presented at the 15th International Conference of the Center for Applied Neuroscience

No Comments
| News

We are delighted to announce that our Ph.D. student, Despina Melanthiou, presented her research on misophonia at the 15th International Conference of the Center of Applied Neuroscience, held at the University of Cyprus. Despina’s presentation showcased our ongoing investigation into the neurophysiological mechanisms underlying misophonia, a condition characterized by intense emotional and physical reactions to […]

Read More »

Posts pagination

1 2 … 12 Next

Recent Posts

  • Zanos lab publishes a short review article on Major Depressive Disorder in Trends in Molecular Medicine January 4, 2026
  • Dr. Zanos appointed as science communication coordinator for European psychedelics research network December 30, 2025
  • Dr. Anna Onisiforou secures €100,000 ERC Vision funding for Multiple Sclerosis research December 24, 2025
  • Zanos Lab research on ketamine’s therapeutic mechanisms in depression and Opioid Use Disorder was presented in a seminar at the University of Haifa December 18, 2025
  • Our Ph.D. student, Despina Melanthiou, featured in national newspaper article on Misophonia research December 14, 2025

Navigation

  • Home
  • News
  • Team Members
    • Lab Director
    • Current Team Members
    • Alumni
  • Research
  • Research Units
    • Translational Neuropharmacology Unit
    • Clinical Neuropsychopharmacology Unit
    • AI & Systems Bioinformatics Unit Cyprus
    • Genetic Epidemiology Unit
  • Facilities
  • Publications
  • Media
  • Join Us
  • Contact
  • More

Translational Neuropharmacology Lab (Zanos Lab) 2026 . Powered by WordPress